Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did 😎Read how

Immutep raises A$6.85M through institutional placement

Published 03/12/2018, 08:47 AM
© Reuters.  Immutep raises A$6.85M through institutional placement
  • Immutep Limited (NASDAQ:IMMP) raises capital through placement of 326.2M new fully paid ordinary shares to Australian institutional investors, Platinum Asset Management Limited and Australian Ethical Investment Limited, former Immutep Chairman, Lucy Turnbull AO and U.S.healthcare institutional investors at an issue price of A$0.021 per new share raising a total of A$6.85M.
  • The proceeds will be used to support Immutep’s ongoing and planned immuno-oncology clinical development programs and for general working capital purposes.
  • Issue date is expected to be around March 14.
  • Following completion of the Placement, Immutep intends to issue Share Purchase Plan to certain eligible existing shareholders. Details of SPP will be communicated as soon as possible.
  • Now read: Your Daily Pharma Scoop: Aimmune Data, Onconova Shares Get A Boost, G1 Therapeutics' Positive Data


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.